Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2021-11-30 2021-11-25
Drug Identification Number 02351889 02351889
Brand name SANDOZ RIZATRIPTAN ODT SANDOZ RIZATRIPTAN ODT
Common or Proper name RIZATRIPTAN ODT RIZATRIPTAN ODT
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 6ODT UD 6ODT UD
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-24 2021-11-24
Estimated end date 2021-12-03 2021-12-03
Actual end date 2021-11-29
Shortage status Resolved Actual shortage
Company comments
Health Canada comments